Are selective contracts with German insurances a smarter reimbursement pathway, Tim Hering?
Within the opportunity of contracting in the German health care market, prices, reimbursement and integrated care paths could be agreed [...]
New CMS Proposal Aims to Expand Coverage for Breakthrough Devices
On Monday, the Centers for Medicare and Medicaid Services announced a proposed rule that would provide four year coverage for [...]
ISPOR Short Course on Medical Devices is Tomorrow
The International Society for Pharmacoeconomics and Outcomes Research's (ISPOR) short course on market access and value assessment of medical devices [...]
Vizient’s Vega Talks Medical Device Industry, Value in Healthcare
In a recent interview with Evidera's Ann Menzie, Vizient's Patrick Vega discussed a number of topics, including key trends in [...]
ISPOR-FDA Summit 2020 Nears
A joint summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Food and Drug Administration (FDA) [...]
Patient-Preference Data in Medical Devices to Take Center Stage at ISPOR-FDA Summit
An upcoming summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in conjunction with the Food and [...]
Optimizing Real-World Evidence in Medical Device Development
The use of real-world data to generate RWE for medical devices by industry has become more prominent in recent years, and more attractive to a variety of stakeholders. It is used frequently to understand the use of the device in the larger clinical setting, but more recently it is also being used for regulatory decision making.
State of the Art Literature Reviews: Why They Fail
Susan Sykes Written by Susan Sykes, Director of Marketing & Communications, Evidence Partners If you’re involved in the [...]
